Literature DB >> 18490447

Desensitization of chemical activation by auxiliary subunits: convergence of molecular determinants critical for augmenting KCNQ1 potassium channels.

Zhaobing Gao1, Qiaojie Xiong, Haiyan Sun, Min Li.   

Abstract

Chemical openers for KCNQ potassium channels are useful probes both for understanding channel gating and for developing therapeutics. The five KCNQ isoforms (KCNQ1 to KCNQ5, or Kv7.1 to Kv7.5) are differentially localized. Therefore, the molecular specificity of chemical openers is an important subject of investigation. Native KCNQ1 normally exists in complex with auxiliary subunits known as KCNE. In cardiac myocytes, the KCNQ1-KCNE1 (IsK or minK) channel is thought to underlie the I(Ks) current, a component critical for membrane repolarization during cardiac action potential. Hence, the molecular and pharmacological differences between KCNQ1 and KCNQ1-KCNE1 channels have been important topics. Zinc pyrithione (ZnPy) is a newly identified KCNQ channel opener, which potently activates KCNQ2, KCNQ4, and KCNQ5. However, the ZnPy effects on cardiac KCNQ1 potassium channels remain largely unknown. Here we show that ZnPy effectively augments the KCNQ1 current, exhibiting an increase in current amplitude, reduction of inactivation, and slowing of both activation and deactivation. Some of these are reminiscent of effects by KCNE1. In addition, neither the heteromultimeric KCNQ1-KCNE1 channels nor native I(Ks) current displayed any sensitivity to ZnPy, indicating that the static occupancy by a KCNE subunit desensitizes the reversible effects by a chemical opener. Site-directed mutagenesis of KCNQ1 reveals that residues critical for the potentiation effects by either ZnPy or KCNE are clustered together in the S6 region overlapping with the critical gating determinants. Thus, the convergence of potentiation effects and molecular determinants critical for both an auxiliary subunit and a chemical opener argue for a mechanistic overlap in causing potentiation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18490447      PMCID: PMC2504881          DOI: 10.1074/jbc.M802426200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

1.  Blocker protection in the pore of a voltage-gated K+ channel and its structural implications.

Authors:  D del Camino; M Holmgren; Y Liu; G Yellen
Journal:  Nature       Date:  2000-01-20       Impact factor: 49.962

2.  Structural determinants of KvLQT1 control by the KCNE family of proteins.

Authors:  Y F Melman; A Domènech; S de la Luna; T V McDonald
Journal:  J Biol Chem       Date:  2000-12-04       Impact factor: 5.157

3.  Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel.

Authors:  M C Sanguinetti; M E Curran; A Zou; J Shen; P S Spector; D L Atkinson; M T Keating
Journal:  Nature       Date:  1996-11-07       Impact factor: 49.962

4.  Inhibition of IKs in guinea pig cardiac myocytes and guinea pig IsK channels by the chromanol 293B.

Authors:  A E Busch; H Suessbrich; S Waldegger; E Sailer; R Greger; H Lang; F Lang; K J Gibson; J G Maylie
Journal:  Pflugers Arch       Date:  1996-10       Impact factor: 3.657

5.  Modulation of single cardiac sodium channels by DPI 201-106.

Authors:  B Nilius; K Benndorf; F Markwardt; T Franke
Journal:  Gen Physiol Biophys       Date:  1987-10       Impact factor: 1.512

Review 6.  Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS Foundation Task Force on LQTS.

Authors:  D M Roden; R Lazzara; M Rosen; P J Schwartz; J Towbin; G M Vincent
Journal:  Circulation       Date:  1996-10-15       Impact factor: 29.690

7.  Ancillary subunits and stimulation frequency determine the potency of chromanol 293B block of the KCNQ1 potassium channel.

Authors:  Glenna C L Bett; Michael J Morales; Derek L Beahm; Michael E Duffey; Randall L Rasmusson
Journal:  J Physiol       Date:  2006-08-03       Impact factor: 5.182

8.  Novel mutations in KvLQT1 that affect Iks activation through interactions with Isk.

Authors:  C Chouabe; N Neyroud; P Richard; I Denjoy; B Hainque; G Romey; M D Drici; P Guicheney; J Barhanin
Journal:  Cardiovasc Res       Date:  2000-03       Impact factor: 10.787

9.  Investigating the putative glycine hinge in Shaker potassium channel.

Authors:  Shinghua Ding; Lindsey Ingleby; Christopher A Ahern; Richard Horn
Journal:  J Gen Physiol       Date:  2005-08-15       Impact factor: 4.086

10.  A novel benzodiazepine that activates cardiac slow delayed rectifier K+ currents.

Authors:  J J Salata; N K Jurkiewicz; J Wang; B E Evans; H T Orme; M C Sanguinetti
Journal:  Mol Pharmacol       Date:  1998-07       Impact factor: 4.436

View more
  21 in total

1.  Polyunsaturated fatty acid analogs act antiarrhythmically on the cardiac IKs channel.

Authors:  Sara I Liin; Malin Silverå Ejneby; Rene Barro-Soria; Mark Alexander Skarsfeldt; Johan E Larsson; Frida Starck Härlin; Teija Parkkari; Bo Hjorth Bentzen; Nicole Schmitt; H Peter Larsson; Fredrik Elinder
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-21       Impact factor: 11.205

2.  Dynamic subunit stoichiometry confers a progressive continuum of pharmacological sensitivity by KCNQ potassium channels.

Authors:  Haibo Yu; Zhihong Lin; Margrith E Mattmann; Beiyan Zou; Cecile Terrenoire; Hongkang Zhang; Meng Wu; Owen B McManus; Robert S Kass; Craig W Lindsley; Corey R Hopkins; Min Li
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

3.  Probing binding sites and mechanisms of action of an I(Ks) activator by computations and experiments.

Authors:  Yu Xu; Yuhong Wang; Mei Zhang; Min Jiang; Avia Rosenhouse-Dantsker; Tsjerk Wassenaar; Gea-Ny Tseng
Journal:  Biophys J       Date:  2015-01-06       Impact factor: 4.033

Review 4.  KCNQ1 channel modulation by KCNE proteins via the voltage-sensing domain.

Authors:  Koichi Nakajo; Yoshihiro Kubo
Journal:  J Physiol       Date:  2015-02-16       Impact factor: 5.182

5.  Stoichiometry of the cardiac IKs complex.

Authors:  William R Kobertz
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-28       Impact factor: 11.205

6.  Effects of protein-protein interactions and ligand binding on the ion permeation in KCNQ1 potassium channel.

Authors:  Horia Jalily Hasani; Aravindhan Ganesan; Marawan Ahmed; Khaled H Barakat
Journal:  PLoS One       Date:  2018-02-14       Impact factor: 3.240

7.  Identification of (R)-N-(4-(4-methoxyphenyl)thiazol-2-yl)-1-tosylpiperidine-2-carboxamide, ML277, as a novel, potent and selective K(v)7.1 (KCNQ1) potassium channel activator.

Authors:  Margrith E Mattmann; Haibo Yu; Zhihong Lin; Kaiping Xu; Xiaofang Huang; Shunyou Long; Meng Wu; Owen B McManus; Darren W Engers; Uyen M Le; Min Li; Craig W Lindsley; Corey R Hopkins
Journal:  Bioorg Med Chem Lett       Date:  2012-08-02       Impact factor: 2.823

Review 8.  Molecular Basis of Cardiac Delayed Rectifier Potassium Channel Function and Pharmacology.

Authors:  Wei Wu; Michael C Sanguinetti
Journal:  Card Electrophysiol Clin       Date:  2016-03-18

9.  The acrylamide (S)-2 as a positive and negative modulator of Kv7 channels expressed in Xenopus laevis oocytes.

Authors:  Sigrid Marie Blom; Nicole Schmitt; Henrik Sindal Jensen
Journal:  PLoS One       Date:  2009-12-11       Impact factor: 3.240

10.  Discovery of a novel activator of KCNQ1-KCNE1 K channel complexes.

Authors:  Karen Mruk; William R Kobertz
Journal:  PLoS One       Date:  2009-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.